Prostatic Neoplasms: all 6,484 studies
Page 33 of 65. Open to participants first (1,413), then studies with results posted, then the rest; newest registration first within each.
- Preventing Catheter Related Bladder Discomfort (CRBD) With Bilateral Pudendal Nerve BlockStatus unknownNCT05022160Early Phase 1
- Postoperative Prognosis Management Service Based mHealth for Prostate Cancer PatientsStatus unknownNCT05021952Not applicable
- Novel MRI Assessment of Prostate Cancer VALIDATE-PROStatus unknownNCT05017181
- Patient Recall of Cancer Screening and DiagnosisWithdrawnNCT05014295Not applicable
- Humidified Forest Oils for Immune System Recovery in Stage I-III Breast or Prostate CancerCompletedNCT05012813Not applicable
- The Peer Genetic StudyCompletedNCT05011799Not applicable
- FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate CancerActive, not recruitingNCT05011188Phase 1/2
- Study of Focal Ablation of the Prostate With NanoTherm® Therapy System for Intermediate-Risk Prostate CancerTerminatedNCT05010759Not applicable
- The Safety and Tolerability of PGV001-based Personalized Multi-peptide Vaccines in the Adjuvant Setting.Active, not recruitingNCT05010200Phase 1
- Timing of Post-prostatectomy PSMA ImagingCompletedNCT05008900Phase 2
- XmAb®20717 (Vudalimab) Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate CancerCompletedNCT05005728Phase 2
- Evaluate the Clinical Usefulness of [F-18]Florastamin PET/CT Imaging Diagnosis Compared to MRI DiagnosisActive, not recruitingNCT05004285Phase 3
- Hypo-Combi Trial: Hypofractionated EBRT Plus HDR-BT Boost for Prostate CancerActive, not recruitingNCT05003752Phase 1/2
- Clinical Use of 68Ga PSMA-11 PET/CT in Diagnosing, Staging and Restaging Prostate CancerNo longer availableNCT05002465
- A Study of MRI-guided High-dose Radiation Therapy in Prostate CancerActive, not recruitingNCT04997018Phase 2
- Therapeutic Efficiency and Response to 2.0 GBq (55mCi) 177Lu-EB-PSMA in Patients With mCRPCStatus unknownNCT04996602Early Phase 1
- Insulin Resistance and Androgen Deprivation TherapyWithdrawnNCT04995978Phase 2
- Health-related Quality of Life, Psychological Distress and Fatigue in Metastatic CRPC Patients Treated With Radium-223CompletedNCT04995614
- A Phase 1 Dose Escalation and Expansion Study Of SHR7280 In Subjects With Hormone Sensitive Prostate CancerCompletedNCT04995042Phase 1
- The Efficacy and Safety of Prostatectomy for Castration-Naive Oligometastatic Prostate CancerCompletedNCT04992026Phase 2
- Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate CancerActive, not recruitingNCT04989946Phase 1/2
- Diagnostic Accuracy and Performance of 18F-PSMA-1007CompletedNCT04986280
- Neoadjuvant Dietary Intervention in Intermediate Risk Prostate CancerActive, not recruitingNCT04985565Not applicable
- Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to DrugsWithdrawnNCT04985357
- Improving Diagnosis and Treatment of Metastatic Advanced Prostate CancerStatus unknownNCT04984395
- Randomized Trial of Five or Two MRI-Guided Adaptive Radiotherapy Treatments for Prostate CancerTerminatedNCT04984343Phase 2
- Optimization of the Core Number and Location for Targeted Prostate BiopsyStatus unknownNCT04983706Not applicable
- Molecular Profiling in Prostate CancerCompletedNCT04983628
- PSMA PET/CT for Biochemical Recurrence Detection in Patients With Prostate CancerCompletedNCT04983459
- Assessment of VMCore Biopsy Versus Standard of Care BiopsyStatus unknownNCT04982536Not applicable
- Robot-Assisted Radical Prostatectomy With or Without Vesicopexy in Patients With Prostate CancerSuspendedNCT04981834Not applicable
- An Investigational Scan (rh PSMA 7.3 PET/MRI) for the Detection of Recurrent Disease and Aid in Radiotherapy Planning in Biochemically Recurrent Prostate CancerCompletedNCT04978675Phase 1
- Effectiveness of Cryotherapy Study for Prostate CancerCompletedNCT04978519Not applicable
- Pharmacokinetics of IA and IV Ga68-PSMA-11 InfusionCompletedNCT04976257Early Phase 1
- Identification of Prostate Cancer Specific Markers in Patients Compared to Healthy ParticipantsActive, not recruitingNCT04964271
- Survival Outcomes in Metastatic Prostate Cancer in the Brazilian Population - Analysis of Individual Characteristics and Treatment Modalities in Different National Health Institutions.CompletedNCT04962919
- HRR Prevalence in LatAm PROSPECT StudyCompletedNCT04962880
- Application of DWI in Diagnosis of Prostate CancerCompletedNCT04962269
- Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing SurgerySuspendedNCT04955808
- MRI-Ultrasound Fusion or Cognitive Registration in MR-targeted Prostate BiopsyStatus unknownNCT04953351Not applicable
- A Behavioral Health Intervention Using Digital Technology in Radiation Therapy for Prostate Cancer PatientsCompletedNCT04946214Not applicable
- TIPOPS (Telemedicine vs In Person Oncology Patient Surveillance)CompletedNCT04936243Not applicable
- Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid TumorsTerminatedNCT04931823Phase 1
- 68Ga-PSMA-11 PET/CT for the Diagnosis of Bone Metastases in Patients With Prostate Cancer and Biochemical Progression During Androgen Deprivation TherapyTerminatedNCT04928820Phase 2
- Health Literacy in Understanding Radiation Therapy Information in Patients Undergoing Definitive Radiation TherapyTerminatedNCT04927559
- The Effect of Metformin in Patients With Metastatic Castration-resistant Prostate CancerStatus unknownNCT04926155Phase 2
- Psma Intensity Can be Altered by Androgen and Phospho-SrC ObstructionCompletedNCT04925648Phase 2
- The Effect of Metformin in Patients With Newly Diagnosed mHSPCActive, not recruitingNCT04925063Phase 2
- Evaluation of the Effect of Endoscopic Urethral Procedures Applied After Radical Prostatectomy on Urinary IncontinenceCompletedNCT04924218Not applicable
- Robotic Radical Perineal Prostatectomy StudyWithdrawnNCT04919057Not applicable
- Biomarker-driven Intermittent Docetaxel in Metastatic Castration-resistant Prostate CancerTerminatedNCT04918810Phase 2
- Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical ProstatectomyActive, not recruitingNCT04915508Phase 2
- PSMA-Targeted 18F-DCFPyL PET/MRI for the Detection of Prostate CancerWithdrawnNCT04910425Phase 2
- Effectiveness of the SpaceOAR Vue System in Subjects With Prostate CancerActive, not recruitingNCT04905069Not applicable
- A Study of JNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate CancerActive, not recruitingNCT04898634Phase 1
- Prediction of the PRONOUNCE Prostate Cancer Trial in Healthcare Claims DataCompletedNCT04897958
- Embr Thermal Device for Hot Flash Management in Prostate CancerCompletedNCT04892914Not applicable
- A Study to Compare the Pharmacokinetics and Safety Between BR9004 and BR9004-1 in Healthy Male VolunteersCompletedNCT04889651Phase 1
- Neoadjuvant SGLT2 Inhibition in Localized Prostate CancerTerminatedNCT04887935Phase 1
- Use of Indocyanine Green During Pelvic Lymph Node Dissection in Prostate Cancer.Status unknownNCT04882618Phase 4
- Evaluation of Length and Quality of Prostate Biopsies Taken by a New Biopsy NeedleStatus unknownNCT04880681Not applicable
- Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery EmbolizationActive, not recruitingNCT04879940Phase 2
- Phase 1 Study of ATRS-2002 in Healthy Male AdultsWithdrawnNCT04879589Phase 1
- Artificial Intelligence Supporting CAncer Patients Across Europe - the ASCAPE ProjectActive, not recruitingNCT04879563Phase 2
- MBM-02 (Tempol) for the Treatment of Biochemical Recurrent Prostate CancerStatus unknownNCT04876755Phase 2
- The Present Study Aims to Compare Patients Who Receive the Investigational Product (177Lu-DOTA-rosopatamab) Plus Standard of Care, in Comparison to Standard of Care OnlyTerminatedNCT04876651Phase 3
- In Situ Clonal Heterogeneity in Prostatic Diagnostic BiopsiesTerminatedNCT04873427
- A Trial of SHR3162 Combined With Apatinib Mesylate Tablets or SHR3162 Monotherapy in Patients With Metastatic Castration Resistant Prostate CancerCompletedNCT04869488Phase 2
- Androgen Deprivation Therapy Combined With Docetaxel for High Risk Prostate CancerStatus unknownNCT04869371Phase 2
- Digital PET/CT Using [Ga-68]PSMA for Characterization of Prostate LesionsCompletedNCT04867603
- Health Status, Quality of Life and Function in Survivors After Radical Treatment for Prostate Cancer. Part I and IIACompletedNCT04863352
- Comparative Study of Abiraterone Acetate Tablets (I) or ZYTIGA® in Patients With Metastatic Castration-resistant Prostate CancerCompletedNCT04862091Phase 2
- Recovery From dNMB Using Different Sugammadex Doses in Elderly Patients Undergoing Robot-assisted ProstatectomyCompletedNCT04854993Phase 3
- 68Ga-PSMA-11 Patients With Newly Diagnosed and Recurrent Prostate Cancer (Firefly)No longer availableNCT04854369
- SLPI for Prostate CancerStatus unknownNCT04854343
- Effect of Peritoneal Fixation on Lymphocele FormationCompletedNCT04853095Not applicable
- Strength, Aging, and Memory in Prostate CancerCompletedNCT04852224
- Stereotactic Body Radiotherapy (SBRT) Post ProstatectomyActive, not recruitingNCT04848909Not applicable
- Ga-68 PSMA-11 PET/CT in Patients With Biochemical Recurrence of Prostate Cancer: Digital PET/CT Versus Analog PET/CTStatus unknownNCT04846894Not applicable
- Phase Ia/Ib Talazoparib + Tazemetostat for mCRPCActive, not recruitingNCT04846478Phase 1
- Stereotactic MRI-guided Radiation Therapy for Localized prostatE CancerActive, not recruitingNCT04845503Not applicable
- Efficacy Evaluation of VERU-111 for mCRPC in Patients Who Have Failed at Least One Androgen Receptor Targeting AgentTerminatedNCT04844749Phase 3
- Phase II Study of Pencil Beam Scanning Proton Stereotactic Body Radiation Therapy for Prostate CancerActive, not recruitingNCT04842890Phase 2
- Positron Emission Tomography (PET) Imaging of Participants With Confirmed Prostate Cancer Using 64Cu-SAR-bisPSMA (PROPELLER)CompletedNCT04839367Phase 1
- PK, PD, Tolerability and Safety of MDPK67b in Healthy VolunteersCompletedNCT04839120Phase 1
- The Effects of Coenzyme A Combined With Abiraterone on Patients With CRPCStatus unknownNCT04839055Phase 1/2
- Verification of Shear Wave Elastography for DEtection of Prostate CancerStatus unknownNCT04836949Not applicable
- Role of Piwi-protein Interacting RNA, miRNA-194 and Amino Acids in Patients With Prostate CancerStatus unknownNCT04835454
- Micro-ultrasound for Prostate Cancer DiagnosisTerminatedNCT04832997Not applicable
- Imaging Guided Surgery to Improve the Detection of Lymph Node Metastases in Prostate Cancer PatientsCompletedNCT04832958Phase 2
- Micro-wave Ablation Under Organ-based Tracking in Patients With Prostate Cancer - FOSTINEStatus unknownNCT04831905Not applicable
- 68Ga-HTK03149 for Use as a Diagnostic RadiopharmaceuticalStatus unknownNCT04831307Not applicable
- 177Lu-PSMA-617 Managed Access Program for mCRPC PatientsNo longer availableNCT04825652
- Detection of Clinically Significant Prostate Cancer Using a Urinary Multimarker SensorStatus unknownNCT04825002Not applicable
- Personalizing Docetaxel Dosing in Advanced Prostate CancerCompletedNCT04823910
- Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPCActive, not recruitingNCT04821622Phase 3
- 18F-DCFPyL PET/MRI in Regional Nodal&Distant Metastases Detection in Intermediate &HR Prostate CancerApproved for marketingNCT04809584
- Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate CancerSuspendedNCT04808427Not applicable
- Comparison of the Effectiveness of Different Conservative Treatment Protocols in Postprostatectomy Urinary IncontinenceCompletedNCT04804839Not applicable
- Prostate Cancer Secondary Screening in Sapienza and Policlinico Umberto IStatus unknownNCT04803188Not applicable